Quantcast
Channel: Comments on: Don’t Worry, Doc: Lilly, Zyprexa & Malpractice
Browsing all 5 articles
Browse latest View live

By: Dan

Yes, a clever marketing tactic. Utopically speaking, however, it would probably be best to educate mental health professionals about all the known variables that need to be considered before...

View Article



By: Lisa Van S

Does that Flier come attached with a big, fat check?…

View Article

By: Hank

I wonder if this tactic could, in fact, backfire. That is, docs that have been prescribing more “heedlessly” suddenly become _more_ “anxious” than they had been. Where am I when Lilly needs me?

View Article

By: Jana Hill

I know many former psychiatric patients. Their reasons for discontinuing psychiatric drugs are not fears generated by news stories. They discontinue because that suspect that the drugs are harming them...

View Article

By: Carol

Do I understand correctly… in order to thwart falling Rxs, Lilly offers a dispensing strategy to insulate doctors from litigation judgments, stemming from a product that carries unwarranted risk. There...

View Article

Browsing all 5 articles
Browse latest View live




Latest Images